Internal Medicine, Hematology & Oncology · San Diego, CA
NPI
1144407115
Since 2008
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
200 W Arbor Dr
San Diego, CA, 92103
Phone (858) 249-6748
Groups this clinician bills Medicare through
Medicare paid, 2024
$103K
1,914 services
Medicare patients, 2024
300
Average age 76
Drug cost, 2024
$4.1M
1,606 prescriptions
Company payments, 2025
$240
From 8 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by James M Randall Jr. was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 642 times for 215 patients. In total James M Randall Jr. billed 1,914 services in 17 codes, and Medicare paid $103K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-11-13.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 642 | 215 | $13.09 | $8,404 |
| 99214 Office E&M - Established | Facility | 333 | 143 | $74.43 | $25K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 241 | 125 | $12.96 | $3,123 |
| 99215 Office E&M - Established | Facility | 234 | 64 | $112.51 | $26K |
| 99214 Office E&M - Established | Office | 114 | 71 | $101.57 | $12K |
| 99213 Office E&M - Established | Facility | 82 | 56 | $49.06 | $4,023 |
| 99213 Office E&M - Established | Office | 61 | 45 | $67.83 | $4,138 |
| 99215 Office E&M - Established | Office | 55 | 33 | $143.24 | $7,878 |
| 99205 Office E&M - New | Facility | 48 | 48 | $140.73 | $6,755 |
| 99212 Office E&M - Established | Office | 21 | 18 | $34.57 | $726 |
| 99497 Care Management/Coordination | Facility | 15 | 13 | $61.36 | $920 |
By year: 2022 $93K for 1,110 services; 2023 $84K for 1,037 services; 2024 $103K for 1,914 services.
Medicare prescription drug claims, 2024
In 2024, the drug James M Randall Jr. prescribed most often to Medicare patients was Prednisone, with 376 prescriptions and refills. In total James M Randall Jr. wrote 1,606 Medicare prescriptions that cost $4.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Prednisone Generic | 376 | 455 | 70 | $1,380 |
| Abiraterone Acetate Generic | 266 | 275 | 44 | $421K |
| Orgovyx Relugolix | 91 | 95 | 19 | $240K |
| Tamsulosin Hcl Generic | 84 | 197 | 25 | $1,073 |
| Nubeqa Darolutamide | 76 | 76 | 11 | $876K |
| Erleada Apalutamide | 76 | 76 | Under 11 | $1.0M |
| Eliquis Apixaban | 44 | 54 | Under 11 | $31K |
| Dexamethasone Generic | 35 | 40 | 16 | $419 |
| Gabapentin Generic | 32 | 44 | Under 11 | $261 |
| Xtandi Enzalutamide | 27 | 27 | Under 11 | $314K |
| Cabometyx Cabozantinib S-Malate | 24 | 24 | Under 11 | $554K |
| Prochlorperazine Maleate Generic | 22 | 22 | 16 | $374 |
| Venlafaxine Hcl Er Venlafaxine Hcl | 20 | 24 | Under 11 | $168 |
| Morphine Sulfate Er Morphine Sulfate | 20 | 20 | Under 11 | $213 |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 19 | 19 | 14 | $171 |
Brand drugs: - claims; generic drugs: 1,198 claims; opioid claims: 94.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid James M Randall Jr. $240 ($240 in general payments such as food, travel and fees) from 8 companies. The largest payer was Merck Sharp & Dohme LLC with $66.4.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.